Matthias Alberer

  • Citations Per Year
Learn More
BACKGROUND Budesonide is effective as initial therapy of mild to moderate Crohn's disease in adults. Superior tolerability to conventional corticosteroids might be attributed to extensive first-pass metabolism of budesonide by cytochrome P450 3A. AIM To evaluate biotransformation and pharmacodynamic action of budesonide in children. METHODS Drug(More)
  • 1